Cite
HARVARD Citation
Cahn, A. et al. (2021). Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58. Diabetes, obesity & metabolism. 23 (1), pp. 29-38. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cahn, A. et al. (2021). Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58. Diabetes, obesity & metabolism. 23 (1), pp. 29-38. [Online].